AERIE PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
AERIE PHARMACEUTICALS INC has filed 818 SEC EDGAR filings since 26 Aug 2005

SEC filing history

Showing 1-25 of 815 matching filings.

Per page
25
Current page
1
SC 13G/A File 005-87680

SC 13G/A filing

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-36152

15-12G

Filing date
01 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-228247

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-216577

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-192030

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-219671

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-221442

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-223364

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-263504

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-216578

S-8 POS

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-36152

25-NSE filing

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87680

MS AMENDMENT

Filing date
10 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .